Construction of an anaplastic thyroid cancer stratification signature to guide immune therapy selection and validation of the pivotal gene HLF through in vitro experiments
IntroductionWhile most thyroid cancer patients have a favorable prognosis, anaplastic thyroid carcinoma (ATC) remains a particularly aggressive form with a median survival time of just five months. Conventional therapies offer limited benefits for this type of thyroid cancer. Our study aims to ident...
Saved in:
Main Authors: | Li Pengping, Yin Kexin, Xie Yuwei, Sun Ke, Li Rongguo, Wang Zhenyu, Jin Haigang, Wang Shaowen, Huang Yuqing |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1478904/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent Progress of Genome Study for Anaplastic Thyroid Cancer
by: Jieun Lee, et al.
Published: (2013-06-01) -
A novel approach to regulate glucose uptake in an anaplastic thyroid cancer cell line
by: Shabnam Heydarzadeh, et al.
Published: (2025-01-01) -
Machine learning-based prognostic model for patients with anaplastic thyroid carcinoma
by: Yihan Sun, et al.
Published: (2025-01-01) -
A case report of anaplastic thyroid carcinoma transformed from small papillary carcinoma successfully detected by ultrasonography in its early stage with review of literature
by: Hiroshi Arimitsu, et al.
Published: (2023-11-01) -
Development of animal models to study aggressive thyroid cancers
by: Shovan Dutta, et al.
Published: (2025-02-01)